David Poon

Head of Corporate Development DCx Bio

Seminars

Wednesday 9th September 2026
Tumor Selectivity Strategies Across Multispecifics, TCEs, & ADCs: What Have we Learnt so Far?
11:40 am
  • Engineering conditional activation through masking and pre-dosing in TCEs and ADCs
  • Discussing dual-target and multispecific approaches
  • Applying induced proximity to ADC specificity to substantially change the behaviour of an ADC
David-Poon speaker at Oncology & Immunology Innovation Partnering